ABC News
@ABCNews·19.3M subscribers·117.3K videos
FDA-approved nasal spray helps patients with treatment-resistant depression
Posted
March 27, 2026
Views
40,122
Likes
1,260
Comments
437
Engagement
4.23%
March 27, 2026
40,122
1,260
437
4.23%
Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.
Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.
Try a name, a topic, or a quoted line
See what was published immediately before and after this episode.
9:47Now PlayingABC News’ Ike Ejiochi follows two patients taking an FDA-approved esketamine nasal spray for their treatment-resistant depression to better understand the drug’s effects.
---
Subscribe to ABC News on YouTube
ABC News is your daily source of breaking national and world news, exclusive interviews and 24/7 live streaming coverage.
Download the ABC News app for the latest headlines and alerts
Connect with ABC News on social media:
Sentinel Indexing in Progress
Metadata and chapters are available. Claim extraction for this episode is pending.
All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.
